US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for ...
The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug for advanced skin cancer, ...
FDA Commissioner Marty Makary has said the agency needs “giant, big ideas” to counter China’s dominance in early-stage ...
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and ...
The FDA granted Priority Review to the supplemental BLA (sBLA) for efgartigimod alfa-fcab for the treatment of adults with acetylcholine receptor antibody (AChR-Ab) seronegative generalized myasthenia ...
US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...
On Thursday, U.S. Senator Richard Blumenthal (D-CT) and Connecticut Attorney General William Tong (D) sent a letter to the ...
The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...
A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results